[go: up one dir, main page]

PL2851073T3 - Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu - Google Patents

Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu

Info

Publication number
PL2851073T3
PL2851073T3 PL13790782T PL13790782T PL2851073T3 PL 2851073 T3 PL2851073 T3 PL 2851073T3 PL 13790782 T PL13790782 T PL 13790782T PL 13790782 T PL13790782 T PL 13790782T PL 2851073 T3 PL2851073 T3 PL 2851073T3
Authority
PL
Poland
Prior art keywords
agent
urinary incontinence
stress urinary
therapeutic agent
prophylactic
Prior art date
Application number
PL13790782T
Other languages
English (en)
Inventor
Masato Nanri
Fukumitsu Sakakibara
Original Assignee
Taiho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co., Ltd. filed Critical Taiho Pharmaceutical Co., Ltd.
Publication of PL2851073T3 publication Critical patent/PL2851073T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C07D211/50Aroyl radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL13790782T 2012-05-15 2013-05-14 Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu PL2851073T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012111843 2012-05-15
EP13790782.0A EP2851073B1 (en) 2012-05-15 2013-05-14 Prophylactic agent and/or therapeutic agent for stress urinary incontinence

Publications (1)

Publication Number Publication Date
PL2851073T3 true PL2851073T3 (pl) 2017-06-30

Family

ID=49583744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13790782T PL2851073T3 (pl) 2012-05-15 2013-05-14 Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu

Country Status (8)

Country Link
US (1) US9603845B2 (pl)
EP (1) EP2851073B1 (pl)
JP (1) JP5908072B2 (pl)
CN (1) CN104302293B (pl)
ES (1) ES2612827T3 (pl)
PL (1) PL2851073T3 (pl)
TW (1) TWI544925B (pl)
WO (1) WO2013172339A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492874B1 (en) 2002-03-29 2011-01-19 XOMA Technology Ltd. Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides
EP3796908B1 (en) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP4251154A4 (en) 2020-11-27 2024-07-31 Santa Farma Ilac Sanayii A.S. SUSTAINED-RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD139212A1 (de) 1978-10-09 1979-12-19 Christian Starke Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten
JPH0611758B2 (ja) 1985-08-14 1994-02-16 大鵬薬品工業株式会社 ベンジル酸−4−ピペリジルエステル誘導体

Also Published As

Publication number Publication date
ES2612827T3 (es) 2017-05-18
US9603845B2 (en) 2017-03-28
CN104302293B (zh) 2017-03-15
JPWO2013172339A1 (ja) 2016-01-12
JP5908072B2 (ja) 2016-04-26
EP2851073A1 (en) 2015-03-25
HK1203159A1 (en) 2015-10-23
US20150051250A1 (en) 2015-02-19
TW201350118A (zh) 2013-12-16
EP2851073B1 (en) 2016-11-09
WO2013172339A1 (ja) 2013-11-21
EP2851073A4 (en) 2015-10-28
TWI544925B (zh) 2016-08-11
CN104302293A (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
IL222702A0 (en) Incontinence treatment
EP2709562A4 (en) FABRIC BACKUP DEVICES AND USE METHOD THEREFOR
EP2785275A4 (en) TREATMENT OF HARNINE CONTINENCE
SG10201506840QA (en) Cytotoxicity-inducing therapeutic agent
PL2802300T3 (pl) Chirurgiczny zestaw i urządzenie do leczenia jaskry
GB201012175D0 (en) Procedure and mechanisms
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
EP2437743A4 (en) OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE
EP2551283A4 (en) ANTIALLERGENIC ACTIVE SUBSTANCE
EP2627331A4 (en) METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES
DK3292875T3 (en) Compositions and methods for treating diseases
LT2771037T (lt) Terapiniai agentai ir jų panaudojimas
IL232715A0 (en) The delayed-release composition for reducing the frequency of urination and a method for using it
ZA201406146B (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
EP2931140A4 (en) Tissue repair equipment and methods
PL2529739T3 (pl) Środek terapeutyczny lub profilaktyczny na choroby dróg żółciowych
IL222479A0 (en) Devices and methods for tissue engineering
IL236226A0 (en) Medicinal or prophylactic agent for mild cognitive impairment
EP2554541A4 (en) THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR FIBROMYALGIA
EP2566483A4 (en) METHOD AND MEANS FOR IMPROVED WOUND HEALING
EP2663343A4 (en) DEVICES AND METHODS FOR TISSUE ENGINEERING
EP2534533A4 (en) METHODS AND DEVICES FOR HALO-OUT AXIS REDUCTION
PL2851073T3 (pl) Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu
IL224632A (en) Fentanyl docushexanavate and its use in the treatment and prevention of cardiovascular disease
ZA201406668B (en) Pharmaceutical composition for treating urinary incontinence and enuresis